Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > IDYA IDEAYA Biosciences > Detailed Quotes

IDYA IDEAYA Biosciences

14.920
+0.810+5.74%
Close 09/30 16:00 ET
14.9200.0000.00%
Post Mkt Price 09/30 16:02 ET
High
15.450
Open
14.100
Turnover
10.39M
Low
14.090
Pre Close
14.110
Volume
692.29K
Market Cap
708.19M
P/E(TTM)
Loss
52wk High
27.255
Shares
47.47M
P/E(Static)
Loss
52wk Low
8.140
Float Cap
490.45M
Bid/Ask %
77.78%
Historical High
28.000
Shs Float
32.87M
Volume Ratio
1.02
Historical Low
2.950
Dividend TTM
--
Div Yield TTM
--
P/B
2.63
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
2.11%
Amplitude
9.64%
Avg Price
15.012
Lot Size
1
Float Cap
490.45M
Bid/Ask %
77.78%
Historical High
28.000
Shs Float
32.87M
Volume Ratio
1.02
Historical Low
2.950
Dividend TTM
--
P/B
2.63
Dividend LFY
--
Turnover Ratio
2.11%
Amplitude
9.64%
Avg Price
15.012
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
IDEAYA Biosciences, Inc. engages in the research and development of oncology-focused precision medicine. The firm focuses on the targeted therapeutics for patients selected using molecular diagnostics. Its product candidate, IDE196, is a protein kinase C inhibitor for genetically-defined cancers having GNAQ or GNA11 gene mutations. The company was founded by Yujiro S. Hata and Jeffrey Hager in June 2015 and is headquartered in South San Francisco, CA.
CEO: Mr. Yujiro S. Hata
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...